Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well fenretinide works in treating children with
recurrent or resistant neuroblastoma. Drugs used in chemotherapy use different ways to stop
tumor cells from dividing so they stop growing or die.